Results 61 to 70 of about 16,167 (200)

Mineralocorticoid receptors in the pathophysiology of vascular inflammation and atherosclerosis.

Frontiers in Endocrinology, 2015
Atherosclerosis is a chronic inflammatory disease of the vasculature that causes significant morbidity and mortality from myocardial infarction, stroke, peripheral vascular disease, and heart failure.
Mary Elizabeth Moss, Mary Elizabeth Moss, Iris Z Jaffe, Iris Z Jaffe   +3 more
doaj   +1 more source

Effects of Mineralocorticoid Receptor Antagonists in Early-Stage Heart Failure With Preserved Ejection Fraction

, 2023
Kazuki Kagami, Masaru Obokata, Tomonari Harada, Yuki Saito, Ayami Naito, Hidemi Sorimachi, Naoki Yuasa, Toshimitsu Kato, Naoki Wada, Takeshi Adachi, Hideki Ishii   +10 more
openalex   +1 more source

Management of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines: The Linx Registry

ESC Heart Failure, 2020
Aims In May 2016, a new version of the European Society of Cardiology (ESC) Guidelines for the management of heart failure (HF) was released. The aim of this study was to describe the management of HF with reduced ejection fraction after the publication ...
Fernando deFrutos, Sonia Mirabet, Luis Ortega‐Paz, Irene Buera, Sara Darnés, Nuria Farré, Bernardo Perez, Raquel Adeliño, Ramón Bascompte, Jordi Pérez‐Rodón, Xavier Aparicio, Mario Sutil‐Vega, Adriana Soto, Mercedes Faraudo, Miguel Cainzos‐Achirica, Nicolás Manito   +15 more
doaj   +1 more source

Potential Impact of Non-Steroidal Mineralocorticoid Receptor Antagonists in Cardiovascular Disease [PDF]

, 2023
Asadur Rahman, Nourin Jahan, Md. Tanvir Rahman, Akira Nishiyama   +3 more
openalex   +1 more source

Need to Revisit Heart Failure Treatment Guidelines for Hyperkalaemia Management During the Use of Mineralocorticoid Receptor Antagonists [PDF]

, 2018
Javed Butler, Shilpa Vijayakumar, Bertram Pitt   +2 more
openalex   +1 more source

Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease [PDF]

, 2020
George L. Bakris, Y Fred F YANG, Bertram Pitt   +2 more
openalex   +1 more source

Mineralocorticoid receptor antagonists modulate ST2 signaling pathway in chronic heart failure [PDF]

, 2013
M. Lopez, Jesús Sánchez‐Más, Domingo A. Pascual‐Figal, Luis Caballero, María Josefa Fernández del Palacio, Giorgia Santarelli, S. Abenza, María T. Pérez-Martínez, Mariano Valdés‐Chávarri, A. M. Lax   +9 more
openalex   +1 more source

Aldosterone receptor antagonists: current perspectives and therapies

Vascular Health and Risk Management, 2013
Jason L Guichard, Donald Clark III, David A Calhoun, Mustafa I Ahmed University of Alabama at Birmingham, Department of Medicine, Division of Cardiovascular Disease, Vascular Biology and Hypertension Program, Birmingham, AL, USA Abstract: Aldosterone is ...
Guichard JL, Clark III D, Calhoun DA, Ahmed MI   +3 more
doaj  

Therapeutic interventions for chronic central serous chorioretinopathy: a comprehensive assessment of systematic reviews

International Journal of Retina and Vitreous
Background A variety of different treatments have been proposed to effectively treat chronic central serous chorioretinopathy but there remains uncertainty regarding the efficacy of a number of treatment options.
Henok Getahun, Rajendra S. Apte
doaj   +1 more source

Safety and Pharmacokinetics of a Novel Non-Steroidal Mineralocorticoid Receptor Antagonist, KBP-5074, in Hemodialysis and Non-Hemodialysis Patients with Severe Chronic Kidney Disease [PDF]

, 2020
Jeffrey J. Connaire, Mark Bush, Jon Ruckle, Fred Yang, Jinrong Liu, Xiaojuan Tan, Ping Wang, Tian Zhou, Min Zhang, Vincent Benn   +9 more
openalex   +1 more source